ZAWYA-PRESSR: Jamjoom Pharma Egypt signs cooperation protocol with Research Institute of Ophthalmology

About this update from Jamjoom Pharmaceuticals Factory Co.

Dr. Ali Yehia: We are committed to active participation in training programs and transferring practical expertise to keep pace with developments in ophthalmologyCairo: Jamjoom Pharma, a leading pharmaceutical company, and the Research Institute of Ophthalmology have signed a cooperation protocol to support and advance medical education and professional training ecosystem in ophthalmology. The agreement also aims to strengthen scientific and research collaboration between the pharmaceutical sector and specialized academic institutions, ultimately contributing to improved healthcare services provided for patients in Egypt.This aligns with Jamjoom Pharma’s strategy to reinforce its role as a trusted scientific partner for healthcare professionals. It reflects the company’s broader vision to support continuous medical education, build capabilities, facilitate knowledge transfer, and foster innovation across medical specialties, within an integrated approach that extends beyond providing high-quality pharmaceutical products.The protocol was signed by Dr. Ali Yehia, Egypt & North Africa Cluster Head at Jamjoom Pharma, and Professor Prof. Dr. Hisham Ali Hashem, Director of the Research Institute of Ophthalmology and Chairman of the Board, in the presence of senior executives from both the company and the institute. The signing underscores the shared commitment of both leadership teams to translate this partnership into practical and sustainable programs on ground.As part of the protocol, the parties will launch a training program, described as the first of its kind in Egypt, focused on transferring hands-on surgical skills using the latest advanced surgical simulation technologies. The program aims to prepare highly qualified medical professionals capable of keeping pace with latest global practices in eye surgery.The program emphasizes developing hands-on surgical skills, providing a safe learning environment that closely replicates real surgical scenarios. By enhancing clinical performance and procedural confidence, it is expected to positively impact patient safety and improve treatment outcomes, representing a meaningful step forward in professional medical education in ophthalmology.Professor Dr. Hisham Ali Hashem, Director of the Research Institute of Ophthalmology and Chairman of the Board, said:“This protocol marks an important step in strengthening coll...

View stock analysis, news, and events for Jamjoom Pharmaceuticals Factory Co.